Clinical Trial Update: Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on integrase and maraviroc intensification for HIV-associated neurocognitive dysfunction shows completed study with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Maraviroc (maraviroc)
• integrase

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2022-03-02